Campbell & CO Investment Adviser LLC Enanta Pharmaceuticals Inc Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $628,059 - $926,937	13,006 New	13,006 $675,000
Q1 2022 May 09, 2022	SELL	$56.06 - $74.11 $201,816 - $266,796	-3,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $216,684 - $350,532	3,600 New	3,600 $269,000
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $214,965 - $279,573	-4,709 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$37.91 - $46.8 $178,518 - $220,381	4,709	4,709 $220,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $173M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.